Ardsley Advisory Partners’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-10,000	Closed	-$31K	–	207
2015 Q4	$31K	Sell	10,000 -5,000	-33%	-$15.5K	﹤0.01%	126
2015 Q3	$66K	Sell	15,000 -10,000	-40%	-$44K	0.02%	121
2015 Q2	$143K	Hold	25,000	–	–	0.02%	155
2015 Q1	$224K	Buy	+25,000	New	+$224K	0.03%	137